Trade AstraZeneca ^AZN

C4X Discovery to receive milestone payment for NRF2 exclusive worldwide license agreement | Valuespectrum.com

Robbins Farley Buys New Shares in Astrazeneca Plc $AZN - Markets Daily

Sigma Planning Corp Cuts Holdings in Astrazeneca Plc $AZN - Zolmax

I asked ChatGPT what will be the first trillion-pound UK stock. It said…

Robbins Farley Purchases New Shares in Astrazeneca Plc $AZN - Stock Observer

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program

Macrophage reprogramming, not CD8 T cell dynamics, characterizes durable disease control following PD-1 blockade in smoldering myeloma

Top Stock Reports for AMD, Costco & AstraZeneca

Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?

Deutsche Bank Aktiengesellschaft Reaffirms Sell Rating for AstraZeneca (LON:AZN) - Markets Daily

Rehmann Capital Advisory Group Grows Stake in Astrazeneca Plc $AZN - Zolmax

Astrazeneca Plc $AZN Shares Bought by Rehmann Capital Advisory Group - Markets Daily

Current therapeutic landscape and future treatment perspectives of MASH

Molecular mechanisms and pathogenesis of MASH

What Does AstraZeneca (LSE:AZN) News Mean For Its Cancer And Pipeline Growth?

Taiwan's Best Companies to Work for in Asia Transformed a Talent Crisis into a Strategic Advantage

What Does AstraZeneca (LSE:AZN) Gain From Its Latest Oncology Advances?

AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer

What Is IDEAYA Biosciences (IDYA) Setting Up With Its IDE849 Phase 3 Path?

Quantitative Investment Management LLC Boosts Stake in Astrazeneca Plc $AZN

AstraZeneca And Daiichi Sankyo Gain EU Nod For Enhertu Plus Pertuzumab In HER2+ Breast Cancer

Astrazeneca Plc $AZN Shares Purchased by Quantitative Investment Management LLC - Stock Observer

Astrazeneca synthesizes new KRAS mutant inhibitors | BioWorld

AstraZeneca Loses Suit Seeking Block on Colorado Pharmacy Law

From Padcev to PF-08634404: Pfizer's Oncology Growth Push

Reviewing AstraZeneca (AZNCF) and Its Competitors - Zolmax

Reviewing AstraZeneca (AZNCF) & The Competition - Markets Daily

Astrazeneca FY2026 EPS Forecast Lowered by Erste Group Bank

Top Manufacturing Stocks To Keep An Eye On - August 30th - Stock Observer

Astrazeneca Plc $AZN Shares Sold by Davidson Investment Advisors

Thornburg Investment Management Inc. Acquires 32,775 Shares of Astrazeneca Plc $AZN - Daily Political

Davidson Investment Advisors Trims Position in Astrazeneca Plc $AZN - Daily Political

Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors

Top Manufacturing Stocks To Research - August 28th - Zolmax

Head-To-Head Analysis: AstraZeneca (AZNCF) versus Its Rivals - Stock Observer

Tezspire Crossing to EoE? Astrazeneca, Amgen say phase III a win

BioCryst is profitable. Now it wants to buy more rare disease drugs

Genentech doubles down on ADC-resistance via $1B DualityBio pact

AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide?

AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success

Glencore and GSK mine euros for popular deals

AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study

AstraZeneca, Amgen's Tezspire Meets Co-Primary, Key Secondary Endpoints In Phase 3 EoE Trial

AstraZeneca drug succeeds in trial for swallowing disorder

Ageing, Innovation and AI: 10 Healthcare Stocks Positioned to Benefit | Financial Horse

AstraZeneca Vietnam upgrades logistics system to support growing operations

Analysts Set Astrazeneca Plc (NYSE:AZN) PT at $211.00 - Zolmax

AstraZeneca lands its largest ever euro deal

AstraZeneca prices €2.55bn euro bond sale across four tranches

Here Are Monday's Top Wall Street Analyst Research Calls: AstraZeneca, Celestica, Chipotle Mexican Grill, Domino's Pizza, Fortune Brands, Golar LNG, Jersey Mike's Subs, Roku, and More

Towards a global collaborative approach to living guideline development in rheumatology

AstraZeneca's Earnings Beat Shows Momentum, But Can its Pipeline Deliver $80 Billion in Revenue?

AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?

AstraZeneca initiated with an Outperform at CICC

Astrazeneca Plc (NYSE:AZN) Given Consensus Rating of "Moderate Buy" by Analysts

Top Pharmaceutical Stocks To Research - August 20th - Daily Political

ET World Leaders Forum 2026: Boris Johnson thanks India for Covid vaccine, credits Brexit for UK rollout

AstraZeneca Loses Second Suit Against Medicare Drug Price Cuts

Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript

Top Pharmaceutical Stocks To Research - August 20th - Markets Daily

7,500 Shares in Astrazeneca Plc $AZN Bought by Westport Asset Management Inc.

Alpro Group partners with AstraZeneca for kidney screening initiative

Evidence-based guidelines for the diagnosis and management of adult-onset IgA vasculitis

AstraZeneca (AZN) - Research Analysts' Weekly Ratings Changes - Zolmax

Foresite Labs Appoints Dr. Jorge Reis-Filho to Chief Strategy Officer and Operating Partner; Joins Foresite Capital as Venture Partner | Morningstar

AstraZeneca (LSE:AZN) Reports Positive Phase III Lung Cancer Trial Results

Here's how much a £10,000 Stocks and Shares ISA could be worth by 2035

Can AstraZeneca (LSE:AZN) Still Be A Bargain After Mixed Trial News?

Mineralys (MLYS) Q2 2026 Earnings Call Transcript

Contrasting AstraZeneca (AZNCF) and Its Rivals - Stock Observer

AstraZeneca's Portfolio and Pipeline Support Solid Long-Term Growth | Morningstar

AstraZeneca Halts Key Lung-Cancer Trial--But Shares Barely Flinch

Promising Manufacturing Stocks To Research - August 17th - Zolmax

AstraZeneca (AZN) Stock Edges Higher Despite Discontinuing Phase III Lung Cancer Study

ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial | Morningstar

AstraZeneca axes NSCLC trial after bispecific deemed unlikely to best Keytruda

AstraZeneca scraps Phase 3 trial of new bispecific in lung cancer

FTSE 100 set to snap six-day losing streak as miners gain

AstraZeneca Ends Phase Three Lung Cancer Drug Trial After Review - Update | Morningstar

AstraZeneca Discontinues Phase 3 EVOLVE-Lung02 Trial Of Volrustomig In Non-small Cell Lung Cancer

Dow Jones Top Company Headlines at 5 AM ET: Alibaba to Sell Videogame Business for at Least $1.5 Billion | AstraZeneca ... | Morningstar

AstraZeneca (AZN) Stock Climbs on Promising Enhertu Cancer Trial Data

AstraZeneca ditches lung cancer treatment trial

HUTCHMED's ORPATHYS-TAGRISSO Combo Shows Significant PFS, OS Benefit In Phase III Trial

AstraZeneca To Cease EVOLVE-Lung02 Phase III Trial Of Volrustomig + Chemotherapy In MNSCLC

AstraZeneca Ends Phase Three Lung Cancer Drug Trial After Review | Morningstar

AstraZeneca lung cancer drug combination extends survival in trial

Enhertu® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival as First-Line Treatment of Patients with HER2 Mutant Advanced Non-Small Cell Lung Cancer in DESTINY-Lung04 Phase 3 Trial

AstraZeneca to discontinue late-stage lung cancer trial for volrustomig

S&CO Inc. Takes Position in Astrazeneca Plc $AZN

Why the Alnylam Sell-Off Looks Overdone -- and What Investors Are Missing

Are Mega-Mergers Back?

Promising Manufacturing Stocks To Research - August 15th - Markets Daily

AstraZeneca (AZNCF) & Its Competitors Financial Review - Stock Observer